ISSN 1308-7649 | E-ISSN 2148-3817
Case Report
Intralabyrinthine Vestibular Schwannoma Responsive to Intratympanic Gentamicin Treatment
(J Int Adv Otol 2017; 13: 285-288)
DOI: 10.5152/iao.2017.2772
European Position Statement on Diagnosis, and Treatment of Meniere’s Disease*
(J Int Adv Otol 2018; 14: 317-321)
DOI: 10.5152/iao.2018.140818
Original Article
Vestibulo-Cochlear Function After Cochlear Implantation in Patients With Meniere’s Disease
(J Int Adv Otol 2018; 14: 18-21)
DOI: 10.5152/iao.2018.4536
Response Over Time of Vertigo Spells to Intratympanic Dexamethasone Treatment in Meniere’s Disease Patients
(J Int Adv Otol 2016; 12: 92-97)
DOI: 10.5152/iao.2016.2177
Endolymphatic Duct Blockage for Refractory Ménière’s Disease: Assessment of Endolymphatic Sac Biopsy on Short-Term Surgical Outcomes
(J Int Adv Otol 2016; 12: 310-315)
DOI: 10.5152/iao.2016.3069
Selective Window Application of Gentamicin+ Dexamethasone in Meniere's Disease
(J Int Adv Otol 2017; 13: 243-246)
DOI: 10.5152/iao.2017.3483
The Clinical Benefit of Device Therapy for Meniere’s Disease in Adults: Systematic Review and Meta-Analysis
(J Int Adv Otol 2019; 15: 121-129)
DOI: 10.5152/iao.2019.5937
The Polymorphic Analysis of the Human Potassium Channel KCNE Gene Family in Meniere’s Disease-A Preliminary Study
(J Int Adv Otol 2019; 15: 130-134)
DOI: 10.5152/iao.2019.5076
The Reliability and Validity of “Dokuz Eylül University Meniere’s Disease Disability Scale”
(J Int Adv Otol 2018; 14: 304-311)
DOI: 10.5152/iao.2017.4386
Clinical Report
Effects of Selective Seratonine Re-Uptake Inhibitors on Meniere’s Disease
(J Int Adv Otol 2017; 13: 276-278)
DOI: 10.5152/iao.2017.3042
Key Words
Author's Corner
Reviewer's Corner
AVES | Copyright © 2019 The European Academy of Otology and Neurotology | Latest Update: 15.08.2019